Comparison of Pharmacokinetic Responses to Three Ketone Esters
NCT07289165 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2025-12-17
Summary
The purpose of this study is to examine how the body absorbs, digests, and metabolizes three different investigational ketone dietary supplements (ketone monoester, ketone tri-ester, ketone salt) and to assess gastrointestinal tolerance or other adverse effects. This study is considered investigational because data are being collected on the differences over time between three active study products. Consumption of these study products are not intended to diagnose, treat, cure, or prevent any disease.
Conditions
- Healthy Volunteer
Interventions
- DIETARY_SUPPLEMENT
-
Dietary Supplement containing Tri-betahydroxybutyrin
Ketone Tri Ester
- DIETARY_SUPPLEMENT
-
Dietary Supplement containing a ketone mono Ester
Ketone Mono Ester
- DIETARY_SUPPLEMENT
-
Dietary supplement containing a ketone salt
Dietary Supplement from a ketone salt
Sponsors & Collaborators
-
NeuroEnergy Ventures, Inc.
lead INDUSTRY
Principal Investigators
-
Tim Ziegenfuss, PhD · CAHS
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-15
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetics and Safety of a New Micellar Glutathione Formulation
NCT06345950 ·Status: COMPLETED ·Phase: NA
-
Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production
NCT03063645 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
NCT01914562 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
NCT02191462 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults
NCT03264079 ·Status: COMPLETED ·Phase: PHASE1
-
EryDex Pharmacokinetics in Healthy Volunteers
NCT01925859 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants
NCT01678573 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition
NCT04640571 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
NCT06658626 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of ABT-126 in Healthy Volunteers
NCT00959634 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients
NCT01798628 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
NCT04910061 ·Status: COMPLETED ·Phase: NA
-
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
NCT03702673 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04249284 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults
NCT04023903 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production
NCT03971123 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects
NCT04654897 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets
NCT01083290 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
NCT04735913 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue
NCT01319916 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
NCT01462786 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
NCT03646799 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers
NCT04479800 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers
NCT02668367 ·Status: COMPLETED ·Phase: PHASE1